Zimmer Biomet Holdings Stock Probability Of Bankruptcy
ZBH Stock | USD 119.43 0.10 0.08% |
Zimmer | Probability Of Bankruptcy |
Zimmer Biomet Holdings Company probability of distress Analysis
Zimmer Biomet's Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
More About Probability Of Bankruptcy | All Equity Analysis
Probability Of Bankruptcy | = | Normalized | | Z-Score |
Current Zimmer Biomet Probability Of Bankruptcy | Less than 6% |
Most of Zimmer Biomet's fundamental indicators, such as Probability Of Bankruptcy, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Zimmer Biomet Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Our calculation of Zimmer Biomet probability of bankruptcy is based on Altman Z-Score and Piotroski F-Score, but not limited to these measures. To be applied to a broader range of industries and markets, we use several other techniques to enhance the accuracy of predicting Zimmer Biomet odds of financial distress. These include financial statement analysis, different types of price predictions, earning estimates, analysis consensus, and basic intrinsic valuation. Please use the options below to get a better understanding of different measures that drive the calculation of Zimmer Biomet Holdings financial health.
Is Zimmer Biomet's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zimmer Biomet. If investors know Zimmer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zimmer Biomet listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.16) | Dividend Share 0.96 | Earnings Share 4.88 | Revenue Per Share 35.43 | Quarterly Revenue Growth 0.063 |
The market value of Zimmer Biomet Holdings is measured differently than its book value, which is the value of Zimmer that is recorded on the company's balance sheet. Investors also form their own opinion of Zimmer Biomet's value that differs from its market value or its book value, called intrinsic value, which is Zimmer Biomet's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zimmer Biomet's market value can be influenced by many factors that don't directly affect Zimmer Biomet's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zimmer Biomet's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zimmer Biomet is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zimmer Biomet's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Zimmer Probability Of Bankruptcy Driver Correlations
Understanding the fundamental principles of building solid financial models for Zimmer Biomet is extremely important. It helps to project a fair market value of Zimmer Stock properly, considering its historical fundamentals such as Probability Of Bankruptcy. Since Zimmer Biomet's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Zimmer Biomet's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Zimmer Biomet's interrelated accounts and indicators.
Click cells to compare fundamentals
The Probability of Bankruptcy SHOULD NOT be confused with the actual chance of a company to file for chapter 7, 11, 12, or 13 bankruptcy protection. Macroaxis simply defines Financial Distress as an operational condition where a company is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from both public financial statements as well as analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors taken into account include analysis of liquidity, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.
Competition |
Based on the latest financial disclosure, Zimmer Biomet Holdings has a Probability Of Bankruptcy of 6.0%. This is 86.14% lower than that of the Health Care Equipment & Supplies sector and 85.43% lower than that of the Health Care industry. The probability of bankruptcy for all United States stocks is 84.94% higher than that of the company.
Zimmer Probability Of Bankruptcy Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Zimmer Biomet's direct or indirect competition against its Probability Of Bankruptcy to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Zimmer Biomet could also be used in its relative valuation, which is a method of valuing Zimmer Biomet by comparing valuation metrics of similar companies.Zimmer Biomet is currently under evaluation in probability of bankruptcy category among related companies.
Zimmer Biomet Main Bankruptcy Drivers
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Return On Assets | 0.0459 | (0.005627) | 0.0171 | 0.011 | 0.0476 | 0.0453 | |
Net Debt | 7.6B | 7.3B | 6.7B | 5.3B | 5.6B | 3.7B | |
Total Current Liabilities | 3.4B | 2.6B | 3.5B | 2.4B | 2.9B | 1.5B | |
Non Current Liabilities Total | 8.8B | 9.7B | 7.3B | 6.7B | 6.2B | 4.8B | |
Total Assets | 24.6B | 24.4B | 23.5B | 21.1B | 21.5B | 13.7B | |
Total Current Assets | 4.7B | 5.1B | 4.9B | 4.4B | 4.6B | 3.4B | |
Total Cash From Operating Activities | 1.6B | 1.2B | 1.5B | 1.3B | 1.6B | 1.1B |
Zimmer Biomet ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Zimmer Biomet's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Zimmer Biomet's managers, analysts, and investors.Environment Score | Governance Score | Social Score |
Zimmer Fundamentals
Return On Equity | 0.0836 | ||||
Return On Asset | 0.044 | ||||
Profit Margin | 0.14 % | ||||
Operating Margin | 0.24 % | ||||
Current Valuation | 30.27 B | ||||
Shares Outstanding | 205.46 M | ||||
Shares Owned By Insiders | 0.12 % | ||||
Shares Owned By Institutions | 90.95 % | ||||
Number Of Shares Shorted | 4.73 M | ||||
Price To Earning | 77.41 X | ||||
Price To Book | 2.05 X | ||||
Price To Sales | 3.46 X | ||||
Revenue | 7.39 B | ||||
Gross Profit | 4.92 B | ||||
EBITDA | 2.34 B | ||||
Net Income | 1.02 B | ||||
Cash And Equivalents | 375.7 M | ||||
Cash Per Share | 2.71 X | ||||
Total Debt | 6 B | ||||
Debt To Equity | 0.48 % | ||||
Current Ratio | 1.98 X | ||||
Book Value Per Share | 60.70 X | ||||
Cash Flow From Operations | 1.58 B | ||||
Short Ratio | 3.67 X | ||||
Earnings Per Share | 4.88 X | ||||
Price To Earnings To Growth | 4.69 X | ||||
Target Price | 137.17 | ||||
Number Of Employees | 18 K | ||||
Beta | 1.02 | ||||
Market Capitalization | 24.52 B | ||||
Total Asset | 21.5 B | ||||
Retained Earnings | 10.38 B | ||||
Working Capital | 1.75 B | ||||
Current Asset | 5.85 B | ||||
Current Liabilities | 1.62 B | ||||
Annual Yield | 0.01 % | ||||
Five Year Return | 0.75 % | ||||
Net Asset | 21.5 B | ||||
Last Dividend Paid | 0.96 |
About Zimmer Biomet Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Zimmer Biomet Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Zimmer Biomet using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Zimmer Biomet Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Zimmer Biomet Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zimmer Biomet's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zimmer Biomet Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zimmer Biomet Holdings Stock:Check out Zimmer Biomet Piotroski F Score and Zimmer Biomet Altman Z Score analysis. Note that the Zimmer Biomet Holdings information on this page should be used as a complementary analysis to other Zimmer Biomet's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Complementary Tools for Zimmer Stock analysis
When running Zimmer Biomet's price analysis, check to measure Zimmer Biomet's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zimmer Biomet is operating at the current time. Most of Zimmer Biomet's value examination focuses on studying past and present price action to predict the probability of Zimmer Biomet's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zimmer Biomet's price. Additionally, you may evaluate how the addition of Zimmer Biomet to your portfolios can decrease your overall portfolio volatility.
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Global Correlations Find global opportunities by holding instruments from different markets | |
AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |
Is Zimmer Biomet's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zimmer Biomet. If investors know Zimmer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zimmer Biomet listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.16) | Dividend Share 0.96 | Earnings Share 4.88 | Revenue Per Share 35.43 | Quarterly Revenue Growth 0.063 |
The market value of Zimmer Biomet Holdings is measured differently than its book value, which is the value of Zimmer that is recorded on the company's balance sheet. Investors also form their own opinion of Zimmer Biomet's value that differs from its market value or its book value, called intrinsic value, which is Zimmer Biomet's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zimmer Biomet's market value can be influenced by many factors that don't directly affect Zimmer Biomet's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zimmer Biomet's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zimmer Biomet is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zimmer Biomet's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.